VNDA Nov 2024 7.000 call

OPR - OPR Delayed Price. Currency in USD

0.0500

0.0000

(0.00%)

As of 10:28AM EST. Market open.

GuruFocus.com
Vanda Pharmaceuticals Inc (VNDA) Q3 2024 Earnings Call Highlights: Revenue Surge Amidst Rising ...
Vanda Pharmaceuticals Inc (VNDA) reports a 23% revenue increase in Q3 2024, driven by Fanapt sales, despite a net loss and increased operating expenses.
Associated Press Finance
Vanda: Q3 Earnings Snapshot
WASHINGTON (AP) — Vanda Pharmaceuticals Inc. VNDA) on Wednesday reported a loss of $5.3 million in its third quarter. The Washington-based company said it had a loss of 9 cents per share.